Literature DB >> 20514063

Targeted cancer therapies.

Saurabh Aggarwal1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514063     DOI: 10.1038/nrd3186

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  7 in total

1.  Antiangiogenic therapy: a universal chemosensitization strategy for cancer?

Authors:  Robert S Kerbel
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

2.  Cancer: mixing cocktails.

Authors:  Charles L Sawyers
Journal:  Nature       Date:  2007-10-25       Impact factor: 49.962

3.  Limits on Medicare's ability to control rising spending on cancer drugs.

Authors:  Peter B Bach
Journal:  N Engl J Med       Date:  2009-01-27       Impact factor: 91.245

4.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

5.  K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Authors:  Christos S Karapetis; Shirin Khambata-Ford; Derek J Jonker; Chris J O'Callaghan; Dongsheng Tu; Niall C Tebbutt; R John Simes; Haji Chalchal; Jeremy D Shapiro; Sonia Robitaille; Timothy J Price; Lois Shepherd; Heather-Jane Au; Christiane Langer; Malcolm J Moore; John R Zalcberg
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

6.  Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

Authors:  Jolien Tol; Miriam Koopman; Annemieke Cats; Cees J Rodenburg; Geert J M Creemers; Jolanda G Schrama; Frans L G Erdkamp; Allert H Vos; Cees J van Groeningen; Harm A M Sinnige; Dirk J Richel; Emile E Voest; Jeroen R Dijkstra; Marianne E Vink-Börger; Ninja F Antonini; Linda Mol; Johan H J M van Krieken; Otilia Dalesio; Cornelis J A Punt
Journal:  N Engl J Med       Date:  2009-02-05       Impact factor: 91.245

7.  Chronic myelogenous leukaemia market.

Authors:  Shane Storey
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

  7 in total
  59 in total

1.  What's fueling the biotech engine--2010 to 2011.

Authors:  Saurabh Aggarwal
Journal:  Nat Biotechnol       Date:  2011-12-08       Impact factor: 54.908

2.  What's fueling the biotech engine-2009-2010.

Authors:  Saurabh Aggarwal
Journal:  Nat Biotechnol       Date:  2010-11       Impact factor: 54.908

3.  Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents.

Authors:  Thapi D Rao; Nestor Rosales; David R Spriggs
Journal:  Mol Cancer Ther       Date:  2011-08-04       Impact factor: 6.261

4.  Medicines as a Service: A New Commercial Model for Big Pharma in the Postblockbuster World.

Authors:  Soeren Mattke; Lisa Klautzer; Tewodaj Mengistu
Journal:  Rand Health Q       Date:  2012-06-01

5.  What's fueling the biotech engine-2011 to 2012.

Authors:  Saurabh Rob Aggarwal
Journal:  Nat Biotechnol       Date:  2012-12       Impact factor: 54.908

6.  A survey of breakthrough therapy designations.

Authors:  Saurabh Rob Aggarwal
Journal:  Nat Biotechnol       Date:  2014-04       Impact factor: 54.908

7.  Pharmacological vs. classical approaches in the design of first in man clinical drug trials.

Authors:  Cornelis A van den Bogert; Adam F Cohen; Hubert G M Leufkens; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2017-10-06       Impact factor: 4.335

8.  A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways.

Authors:  Dayun Yang; Wensong Luo; Jichuang Wang; Min Zheng; Xin-Hua Liao; Nan Zhang; Wenxian Lu; Long Wang; Ai-Zheng Chen; Wen-Guo Wu; Hekun Liu; Shi-Bin Wang; Xiao Zhen Zhou; Kun Ping Lu
Journal:  J Control Release       Date:  2017-11-21       Impact factor: 9.776

9.  Towards patient-based cancer therapeutics.

Authors:  Stuart L Schreiber; Alykhan F Shamji; Paul A Clemons; Cindy Hon; Angela N Koehler; Benito Munoz; Michelle Palmer; Andrew M Stern; Bridget K Wagner; Scott Powers; Scott W Lowe; Xuecui Guo; Alex Krasnitz; Eric T Sawey; Raffaella Sordella; Lincoln Stein; Lloyd C Trotman; Andrea Califano; Riccardo Dalla-Favera; Adolfo Ferrando; Antonio Iavarone; Laura Pasqualucci; José Silva; Brent R Stockwell; William C Hahn; Lynda Chin; Ronald A DePinho; Jesse S Boehm; Shuba Gopal; Alan Huang; David E Root; Barbara A Weir; Daniela S Gerhard; Jean Claude Zenklusen; Michael G Roth; Michael A White; John D Minna; John B MacMillan; Bruce A Posner
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

10.  The Weak Link: Optimization of the Ligand-Nanoparticle Interface To Enhance Cancer Cell Targeting by Polymer Micelles.

Authors:  Jing Wang; Michael Dzuricky; Ashutosh Chilkoti
Journal:  Nano Lett       Date:  2017-09-05       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.